Close

What is a Community of Practice?

A community of practice is a group of healthcare professionals who meet to share knowledge, discuss challenges and experiences, and facilitate patient referral based on tumor type.

Since 2018, Q-CROC has established and coordinates several communities of practice in oncology clinical research.

Who Can Participate?

Physicians, research nurses, and research coordinators. At the heart of the community of practice concept is the idea of learning by interacting with others.

BENEFITS OF COMMUNITIES OF PRACTICE

REFER PATIENTS

To establish an effective system for referring patients between centers

​

CIRCULATE INFORMATION

Quickly inform all centers of ongoing trials and upcoming ones

INCREASE VISIBILITY

To increase the community’s visibility among trial promoters

Thoracic (Résot)

Launched in 2018, RÉSOT was the first community of practice implemented by Q-CROC. Today, it has more than 80 members in 16 hospital centers across Quebec. This community fosters knowledge sharing, harmonized practices, collaboration across institutions, and enhanced access to clinical trials in thoracic oncology.

Dr. Nathalie Daaboul (Hôpital Charles-Le Moyne) acts as a leader for RÉSOT.

Neuro-Oncology

Launched in the winter of 2022, this community brings together nearly 70 physicians from 11 centres across Quebec. It aims to enhance clinical trial recruitment, encourage inter-institutional patient referrals, and foster the exchange of knowledge and best practices in neuro-oncology. The community is currently led by Dr. Roberto Diaz (MUHC).

Melanoma

Launched in 2023, the Melanoma Community of Practice includes nearly 60 members from several hospital centres across Quebec. It is led by Dr. Rahima Jamal (CHUM).

Gastrointestinal

Launched in the fall of 2020, this Community of Practice brings together representatives from a dozen hospital centres across Quebec. It aims to foster collaboration among teams specializing in gastrointestinal oncology, facilitate the exchange of best practices, address clinical challenges, and strengthen partnerships between centres. The community also works to optimize clinical trial recruitment and improve patient access to new therapeutic approaches. Dr. Francine Aubin (CHUM) serves as the community leader.

Neurology, Radiology & Gynecology

Established in 2023, this multidisciplinary Community of Practice was created under the leadership of Dr. Jean-Paul Bahary (CHUM). It brings together experts from a range of specialties to foster a collaborative approach to the development of clinical trials. Its primary objectives are to increase the number of studies available and promote knowledge exchange and collaboration among participating teams.

Gynecology

Founded in 2021 by Dr. Diane Provencher (CHUM), this Community of Practice brings together professionals involved in clinical research in gynecologic oncology, with a focus on ovarian cancer. It promotes knowledge sharing, collaboration among centres, and improved access to clinical trials for patients.

Bladder

Established in 2024, this Community of Practice is led by Dr. Wassim Kassouf (MUHC). It aims to strengthen collaboration among clinical research teams, optimize patient recruitment, and foster the exchange of best practices in urologic oncology.

Molecular Genetics

Launched in 2024 under the leadership of Dr. Alan Spatz (Jewish General Hospital), this Community of Practice brings together experts in molecular pathology, genetics, and oncology. It promotes the integration of biomarkers and precision medicine into clinical trials while supporting knowledge sharing and the alignment of best practices.

Kidney

Established in 2025, the Kidney Cancer Community of Practice, led by Dr. Michel Pavic (CHU de Sherbrooke), provides a forum for specialists to discuss complex clinical cases, share expertise, and support optimal patient care. The community also fosters collaboration among clinical research teams, promotes the development of research projects, enhances patient recruitment for clinical trials, and encourages knowledge sharing in renal oncology.

Phase I Trials

Currently under development, this Community of Practice will bring together teams involved in Phase I clinical trials across Quebec. Its main goal will be to facilitate the timely exchange of information on available early-phase studies, thereby improving the identification and recruitment of eligible patients.
contact us

if you have any questions or are interested in joining a community of practice